Refine Technology
 
 

click to download this page

 

 

 
Which Process Option is Right for Me?

A Comparison of Fed-Batch, Concentrated Fed-Batch, Perfusion and Concentrated Perfusion

When determining how to develop a bioprocess for your drug candidate, there are many key decisions about how to proceed including choosing a cell line, whether to outsource or keep in-house, and what type of bioprocess is most economic.

The old fed-batch and perfusion processes are well known but both have limitations. If you wish to move to a modern production platform, which one is best?

If you already have a facility this will impact significantly your cost base and therefore your choice, but today, most people wish to evaluate all opportunities that could reduce the cost of development and the cost of manufacture. Here is an overview about the four main process options commonly available. (note that batch processing is ignored here)

Typical questions may include:
Should I use fed-batch rather than perfusion? Which is lower cost? Which involves less risk? What about the new concentrated fed-batch or concentrated perfusion processes? How do I know which process option is right for me?

…here are some ideas and answers:

 

Refine droplet trio

Perfusion, Concentrated Perfusion, Fed-Batch, Concentrated Fed-Batch CFB™

Use Perfusion if you want to:

  • keep a low cell density of 30m or less for reasons of cell or product stability, for example because the concentration of a required toxic molecule will be too difficult to control.
  • replicate a process that is moving from older style perfusion technology, such as a spin filter or cell settler, and just wish to benefit from the ATF System’s improved reliability and gain a filtered product stream - but wish to maintain a similar cell density as previously.

Use Concentrated Perfusion (ATF-perfusion) if you want to:

  • reduce the size of bioreactor required to produce to same amount of product as in fed-batch or perfusion
  • reduce the time taken to produce X kilograms of your molecule
  • reduce USP development times
  • standardize process control and improve the reliability of reactor performance
  • reduce the complexity of media development and use only a single medium feed
  • remove contaminants and by-products from the reactor and improve product quality
  • maintain a constant environment for cell growth and/or product expression
  • utilize an existing DSP train that is suited to receive one or two vessel volumes per day of clarified material at 1-2g/L concentration.
  • take advantage of moving towards continuous processing in downstream activities.

Use Concentrated Fed-Batch (ATF-fedbatch) if you want to:

  • take advantage of all the benefits of concentrated perfusion, but also require a single concentrated product harvest directly from the reactor
  • have a short production time comparable to fed-batch, e.g. 12-16 days

Use Fed-Batch if you want to:

  • utilize effectively your existing 10,000L or 20,000L reactor

Back to top

Refine droplet trio Comparison Table
  Perfusion Concentrated
Perfusion
Fed-Batch Concentrated
Fed-Batch
Feed Complete medium Complete medium Feed concentrate (multiple) Complete medium
Environment Constant Constant Changing Constant
Osmolarity Constant Constant Increasing Limited or no change
Waste / toxic molecules Removed Removed Accumulated Removed
Product residence time Low Low High High
Stability of environment
for product
High High Low Moderate
Typical Process Duration 1-2 months 1-2 months 1-3 weeks 2-3 weeks
Typical cell concentration
10-30m 60-120m 10-30m 70-200m
Typical cell viability during production 75-95% 75-95% 30-95% 90-95%
Typical cell viability at harvest 75-95% 75-95% 30-70% 80-90%
Compatible with disposable bioreactors Yes Yes Yes Yes
  Perfusion Concentrated
Perfusion
Fed-Batch Concentrated
Fed-Batch
Compatible with
ATF-cellbanking?
Yes Yes Yes Yes
Compatible with
ATF-manufacturing?
Yes Yes Yes Yes
Seed train (liters) 8 Stages:
1ml (vial), 5ml, 25ml, 125ml, 600ml, 3L, 15L, 75L
8 Stages:
1ml (vial), 5ml, 25ml, 125ml, 600ml, 3L, 15L, 75L
10 Stages:
1ml (vial), 5ml, 25ml, 125ml, 600ml, 3L, 15L, 75L, 400L, 2000L
8 Stages:
1ml (vial), 5ml, 25ml, 125ml, 600ml, 3L, 15L, 75L
Seed train with
ATF-manufacturing platform (liters)
2 Stages:
100ml (bag), 10L
2 Stages:
100ml (bag), 10L
3 Stages:
100ml (bag), 10L, 500L
2 Stages:
100ml (bag), 10L
Typical manufacturing vessel size
500L 500L 10,000L 500L
Media cost per litre Moderate Moderate High Moderate
Media volume required High (1-2vvd) High (1-2vvd) Low (1vv) Moderate (10-15vv)
Harvest Daily / constant Daily / constant 1 per batch 1 per batch
Process control requirements High High Moderate High
Operational skill required High High Moderate Moderate
Alkali addition Low Low Moderate Low
Compatible with continuous DSP Yes Yes No No
§Output from 1000L reactor, per day 0.2kg 0.8kg n-a n-a
§Output from 1000L reactor, per run (CHO cell data) 6kg
(20m cells per ml)
(30 days)
24kg
(80m cells per ml)
(30 days)
1.2kg
(peak 20m cells per ml)
(14 days)
17kg
(peak 100m cells per ml)
 (18 days)
Time to produce 10 Kg of product 1-2 Batches
~7 weeks
1 Batch
~2 weeks
8-9 Batches
~22 weeks
1 Batch
~2 weeks
Yearly output from 1000L reactor 60kg
(10 runs)
240kg
(10 runs)
24kg
(20 runs)
255kg
(15 runs)
Reactor size required to produce ~250Kg per year
4x 1,000L 1x 1,000L 1x 10,000L 1x 1,000L
§ Model data taken from CMC ICOS webinar 2009 presented through Bioprocess International (available in the download center) and from one of Refine Technology’s pharmaceutical clients.
Process Comparison Table by Minnesota University
  Perfusion * Concentrated Perfusion ** Fed-Batch * Concentrated
Fed-Batch **
Scale 400L 400L 15,000L 400L
Length 50-180 days 30-60 days 15-20 days 10-20 days
Cell Density 6-100 x 106 60-120 x 106 6-10 x 106 70-200 x 106
Cell Line Stability
- - + +
Product Concentration +/- + + ++
Productivity + + + +
Product Residence Time + + - -
Process Simplicity - - - -
Process Control - - - -
Contamination Risk - - + +
Operation Costs + + +/- +
* Data from CD-ROM Cell Retention and Perfusion, by Chun Zhang, Cell and Tissue Reactor Engineering,
© 2003 University of Minnesota
** Data estimated on similar basis by Refine Technology
 
 
 
 
 

HOME | ABOUT US | TECHNOLOGY | APPLICATIONS | DOWNLOAD CENTER | NEWS & EVENTS | CONTACT US
Refine Technology Copyright 2010